Since March this year, the ninth batch of state-organized centralized drug procurement has been implemented one after another. The latest news from the National Health Insurance Administration, which has been implemented in all provinces across the country. The result?
The ninth batch of state-organized drug centralized procurement was implemented
Effectively reduce the burden of medical treatment for patients
Mr. Wang, a 38-year-old resident of Nanjing, Jiangsu Province, has kidney failure due to chronic kidney disease and is on dialysis three times a week at a hospital near his home. In addition, Mr. Wang has been taking Lanthanum carbonate chewable tablets every day to control his blood phosphorus levels, and has been taking them for more than 5 years now.
Ms. Tian, a family member of the patient: Although the effect is good, the price is still relatively expensive, and at the beginning, he had more complications and more medications, and the high price still has a certain burden for us.
At present, lanthanum carbonate chewable tablets have been included in the ninth batch of national drug centralized procurement, which has greatly reduced the burden of medical treatment on patients.
Yang Guang, chief physician of the Department of Nephrology of Jiangsu Provincial People's Hospital: The price of a single box was more than 220 yuan before centralized procurement, and now it is 59 yuan after centralized procurement, a decrease of 75%. In a year, this drug alone can reduce the patient's drug cost by about 18,000 yuan.
According to reports, a total of 180 medical institutions in Nanjing, Jiangsu Province participated in the ninth batch of state-organized drug centralized procurement, involving a total of 15.91 million tablets of agreed procurement, and it is expected to save about 30.39 million yuan annually.
Liu Qi, second-level chief clerk of the Medical Price Procurement Department of Nanjing Medical Security Bureau, Jiangsu Province: The average decline of the ninth batch of drug centralized procurement is about 58%, mainly including cardiovascular and cerebrovascular diseases, infectious diseases, and gastrointestinal diseases, and there are about 11 categories. There are also some shortage drugs, among which the highest reduction is dexamethasone sodium phosphate injection for the treatment of allergic diseases, which can reach 98%.
The ninth batch of state-organized drug centralized procurement
It is estimated that it can save 18.2 billion yuan in drug costs every year
The state organizes centralized drug procurement to provide better services for patients by reducing the inflated prices of drugs and medical consumables, and also provides greater space for the reform of medical treatment, medical insurance, and pharmaceutical linkage. According to the National Health Insurance Administration, since the launch of the ninth batch of centralized drug procurement, the supply of selected products has been generally stable, and it is expected to save patients 18.2 billion yuan in drug costs every year.
According to the National Health Insurance Administration, the price of drugs with rational use of drugs that are under key monitoring in many countries, such as rabeprazole sodium enteric-coated tablets for the treatment of gastrointestinal diseases, has been significantly reduced.
Patient Ms. Li: I have been taking rabeprazole sodium for a long time, and the course of treatment in the previous month was about 100 yuan, and the price of the medicine is much lower today, only more than 6 yuan.
The price of drugs such as lenalidomide capsules for the treatment of multiple myeloma and atomoxetine hydrochloride for the treatment of ADHD in children has dropped by more than 90%.
Gu Hai, Director of the Health Policy and Management Research Center of Nanjing University: The price of lenalidomide capsules, which was originally 200 yuan per box during the patent period, is now only 15 yuan, so it probably saves patients nearly 3,800 yuan per month. The original price of atomoxetine hydrochloride was more than 10 yuan, but now it is only more than 1 yuan, so it saves nearly 10,000 yuan for patients every year.
It is reported that the regional price difference of the ninth batch of state-organized drug centralized procurement is more reasonable. Compared with the previous batches of centralized drug procurement, the ninth batch of state-organized centralized drug procurement has shown many new changes.
Gu Hai, Director of the Health Policy and Management Research Center of Nanjing University: First, from the perspective of drugs, it involves 11 treatment categories, especially including anesthetics, emergency drugs and other shortage drugs, and is more inclined to clinical and surgical treatment. Second, the contract period of the drug has been extended from 2 years to 4 years. Third, we have added some specific measures to combat bid-rigging.
In the next step, the National Health Insurance Administration will strengthen the supply guarantee of selected products in centralized procurement by organizing the signing of procurement agreements in a timely manner, smoothing the feedback channels of medical institutions, and actively coordinating and responding to short-term surges in demand.